Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing - Ascertaining Serial Cancer Patients to Enable New Diagnostic

NCT04213326 is registered in ClinicalTrials.gov with Exact Sciences Corporation as lead sponsor.

NCT NCT04213326
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04213326 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Detecting Cancers Earlier Through Elective Plasma-based CancerSEEK Testing - Ascertaining Serial Cancer Patients to Enable New Diagnostic
Lead sponsor
Exact Sciences Corporation
Phase
Observational
Overall status
Completed
Start date
November 18, 2019
Completion date
January 29, 2021
Enrollment
6,400 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

early cancer detection